Catalyst Wire Dossier Catalyst Wire Dossier

Luxceptar

· Kiadis Pharma Netherlands B.V.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Luxceptar, covering 2020-02-17 to 2020-02-17. Get the full timeline:

Most recent: EMA Application withdrawn: Luxceptar — Kiadis Pharma Netherlands B.V.

See pricing